Simos kedikoglou biography of michael
•
Subscribe to this RSS feed
Euro-Med Journalism Institute (3)
The 3rd annual Euro-Mediterranean Journalism Institute (EMJI) took place October 18-26, 2008 in Athens, Greece. EMJI was organized by the Greek Association for Atlantic and European Cooperation(GAAEC) and The Fund for American Studies (TFAS), under the auspices of the Secretariat General of Information, Ministry of State, of the Greek Government.
EMJI brought together approximately 50 working journalists and journalism students from more than two dozen countries in the Balkans and Mediterranean regions, and around the world. EMJI was developed in response to a growing recognition that journalists around the world must be empowered with the knowledge and skills needed to objectively report on a variety of international political, economic and cultural issues. Instructors and guest lecturers at the Institute were drawn from the United States and the Euro-Med area. They include economic and public policy expert
•
Relevant links and documents
The sudden closure last week (11/6) of ERT's TV and radio channels has been roundly criticized bygd institutions both in europe and around the world.
Organizations including the europeisk Parliament, the Council of Europe, the OSCE and press associations have issued expressions of shock and condemnation, bolstering the statement of condemnation signed bygd the EBU and more than 50 Directors General of its European membership including the BBC, ARD, ZDF, Rai, RTVE, RTBF and France Télévisions.
The EBU has also been inundated with emails of from individuals and support for its online petition has reached tens of thousands.
europeisk Parliament - Overnight closure of till er by Greek government ‘antidemocratic’
Brussels, 19 June - Yesterday, members of the europeisk Parliament’s Culture Committee meeting in Brussels joined voices to heavily criticise the Greek government’s sudden decision to close ERT gods we
•
Cleveland Clinic cardiologists make history, become first in world to implant new heart failure device
“This could be an important advancement for heart failure patients, requiring just one procedure to deliver two important therapies and prevent sudden cardiac death,” Wilkoff, principal investigator for the INTEGRA-D trial, said in a prepared statement. “The hope is that this rechargeable technology—with a potential battery life of up to 20 years—will significantly reduce the need for replacement procedures.”
“We are looking forward to studying this new technology to determine its potential to advance treatments for patients living with heart failure,” added Varma, national primary investigator.
The INTEGRA-D clinical trial will examine data from 300 patients treated at one of 75 facilities, focusing on the device’s ability to treat heart failure and episodes of ventricular tachycardia/ventricular fibrillation at the same time. Patients will be followed for a minimum of two y